Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies
Open Access
- 16 June 2023
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (10) , 5557-5577
Abstract
Neurodegenerative disorders (NDD) have grabbed significant scientific consideration due to their fast increase in prevalence worldwide. The specific pathophysiology of the disease and the amazing changes in the brain that take place as it advances are still the top issues of contemporary research. Transcription factors play a decisive role in integrating various signal transduction pathways to ensure homeostasis. Disruptions in the regulation of transcription can result in various pathologies, including NDD. Numerous microRNAs and epigenetic transcription factors have emerged as candidates for determining the precise etiology of NDD. Consequently, understanding by what means transcription factors are regulated and how the deregulation of transcription factors contributes to neurological dysfunction is important to the therapeutic targeting of pathways that they modulate. RE1-silencing transcription factor (REST) also named neuron-restrictive silencer factor (NRSF) has been studied in the pathophysiology of NDD. REST was realized to be a part of a neuroprotective element with the ability to be tuned and influenced by numerous microRNAs, such as microRNAs 124, 132, and 9 implicated in NDD. This article looks at the role of REST and the influence of various microRNAs in controlling REST function in the progression of Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) disease. Furthermore, to therapeutically exploit the possibility of targeting various microRNAs, we bring forth an overview of drug-delivery systems to modulate the microRNAs regulating REST in NDD. Graphical abstractKeywords
Funding Information
- Manipal Academy of Higher Education, Manipal
This publication has 168 references indexed in Scilit:
- ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditionsProceedings of the National Academy of Sciences, 2013
- Extensive Alternative Splicing of the Repressor Element Silencing Transcription Factor Linked to CancerPLOS ONE, 2013
- Regulation of RE1 Protein Silencing Transcription Factor (REST) Expression by HIP1 Protein Interactor (HIPPI)Journal of Biological Chemistry, 2011
- REST/NRSF governs the expression of dense-core vesicle gliosecretion in astrocytesJournal of Cell Biology, 2011
- MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathwayNature Medicine, 2010
- PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseScience Translational Medicine, 2010
- Strengths and Limitations of Laboratory Procedures for MicroRNA DetectionCancer Epidemiology, Biomarkers & Prevention, 2010
- Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in SynucleinopathiesJournal of Biological Chemistry, 2010
- miR-124 regulates adult neurogenesis in the subventricular zone stem cell nicheNature Neuroscience, 2009
- Huntingtin Regulates RE1-silencing Transcription Factor/Neuron-restrictive Silencer Factor (REST/NRSF) Nuclear Trafficking Indirectly through a Complex with REST/NRSF-interacting LIM Domain Protein (RILP) and Dynactin p150GluedJournal of Biological Chemistry, 2008